11/25/24 06:03 | 11/21/24 | GLSI | Health | Drug | Pharmaceutical Preparations | Thompson Jaye | TX | O | VP Clini | P | 13 | 12.91 | 0 | 1 | 0 | 264 | D | | | | | | | | | | | | | | |
9/30/24 06:04 | 9/26/24 | GLSI | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 22 | 14.63 | 0 | 2 | 0 | 5,536 | D | | | | | | | | | | | | | | |
9/16/24 06:05 | 8/12/24 | GLSI | Health | Drug | Pharmaceutical Preparations | Thompson Jaye | TX | O | VP Clini | P | 11 | 13.85 | 0 | 1 | 0 | 263 | D | | | | | | | | | | | | | | |
8/8/24 06:05 | 8/6/24 | GLSI | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 28 | 13.81 | 0 | 2 | 0 | 5,535 | D | | | | | | | | | | | | | | |
8/7/24 06:05 | 8/5/24 | GLSI | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 72 | 13.18 | 0 | 6 | 0 | 5,533 | D | | | | | | | | | | | | | | |
8/5/24 06:05 | 8/2/24 | GLSI | Health | Drug | Pharmaceutical Preparations | Thompson Jaye | TX | O | VP Clini | P | 15 | 15.15 | 0 | 1 | 0 | 262 | D | | | | | | | | | | | | | | |
7/24/24 06:05 | 7/23/24 | GLSI | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 24 | 15.89 | 0 | 2 | 0 | 5,527 | D | | | | | | | | | | | | | | |
7/22/24 06:05 | 7/18/24 | GLSI | Health | Drug | Pharmaceutical Preparations | Thompson Jaye | TX | O | VP Clini | P | 16 | 16.00 | 0 | 1 | 0 | 261 | D | | | | | | | | | | | | | | |
6/17/24 06:10 | 6/13/24 | GLSI | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 2,500 | 14.30 | 0 | 175 | 3 | 5,526 | D | | | | | | | | | | | | | | |
4/3/24 06:10 | 4/1/24 | GLSI | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 57 | 19.08 | 0 | 3 | 0 | 5,351 | D | | | | | | | | | | | | | | |
3/26/24 06:05 | 3/22/24 | GLSI | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 50 | 19.98 | 0 | 3 | 0 | 5,348 | D | | | | | | | | | | | | | | |
3/22/24 06:02 | 3/20/24 | GLSI | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 27 | 17.68 | 0 | 2 | 0 | 5,345 | D | | | | | | | | | | | | | | |
3/7/24 09:41 | 3/5/24 | GLSI | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P.a | 44 | 12.49 | 0 | 4 | 0 | 5,344 | D | | | | | | | | | | | | | | |
3/7/24 06:05 | 3/5/24 | GLSI | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 381 | 12.49 | 0 | 31 | 1 | 5,344 | D | | | | | | | | | | | | | | |
3/6/24 06:05 | 3/4/24 | GLSI | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 53 | 13.03 | 0 | 4 | 0 | 5,340 | D | | | | | | | | | | | | | | |
2/21/24 06:05 | 2/16/24 | GLSI | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 121 | 11.16 | 0 | 11 | 0 | 5,336 | D | | | | | | | | | | | | | | |
2/20/24 06:04 | 2/15/24 | GLSI | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 141 | 11.07 | 0 | 13 | 0 | 5,325 | D | | | | | | | | | | | | | | |
11/14/23 06:05 | 11/10/23 | GLSI | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 51 | 10.17 | 0 | 5 | 0 | 5,313 | D | | | | | | | | | | | | | | |
11/7/23 06:15 | 11/3/23 | GLSI | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 32 | 9.11 | 0 | 4 | 0 | 5,308 | D | | | | | | | | | | | | | | |
10/31/23 06:16 | 10/27/23 | GLSI | Health | Drug | Pharmaceutical Preparations | Thompson Jaye | TX | O | VP Clini | P | 4 | 8.57 | 0 | 1 | 0 | 260 | D | | | | | | | | | | | | | | |
10/30/23 06:15 | 10/26/23 | GLSI | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 20 | 7.97 | 0 | 3 | 0 | 5,304 | D | | | | | | | | | | | | | | |
10/27/23 06:15 | 10/25/23 | GLSI | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 20 | 7.91 | 0 | 3 | 0 | 5,302 | D | | | | | | | | | | | | | | |
10/12/23 06:05 | 10/10/23 | GLSI | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 9 | 9.07 | 0 | 1 | 0 | 5,299 | D | | | | | | | | | | | | | | |
10/5/23 06:05 | 10/4/23 | GLSI | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 17 | 8.63 | 0 | 2 | 0 | 5,298 | D | | | | | | | | | | | | | | |
9/28/23 06:05 | 9/26/23 | GLSI | Health | Drug | Pharmaceutical Preparations | Thompson Jaye | TX | O | VP Clini | P | 5 | 8.71 | 0 | 1 | 0 | 260 | D | | | | | | | | | | | | | | |
9/21/23 06:05 | 9/19/23 | GLSI | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 36 | 8.95 | 0 | 4 | 0 | 5,296 | D | | | | | | | | | | | | | | |
9/13/23 06:05 | 9/11/23 | GLSI | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 9 | 9.48 | 0 | 1 | 0 | 5,292 | D | | | | | | | | | | | | | | |
8/24/23 06:05 | 8/22/23 | GLSI | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 10 | 9.97 | 0 | 1 | 0 | 5,291 | D | | | | | | | | | | | | | | |
8/8/23 06:05 | 8/4/23 | GLSI | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 21 | 10.55 | 0 | 2 | 0 | 5,290 | D | | | | | | | | | | | | | | |
7/25/23 06:15 | 7/21/23 | GLSI | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 9 | 9.20 | 0 | 1 | 0 | 5,288 | D | | | | | | | | | | | | | | |
7/17/23 06:15 | 7/13/23 | GLSI | Health | Drug | Pharmaceutical Preparations | Thompson Jaye | TX | O | VP Clini | P | 2 | 9.49 | 0 | 0 | 0 | 259 | D | | | | | | | | | | | | | | |
5/18/23 06:01 | 5/17/23 | GLSI | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 12 | 11.69 | 0 | 1 | 0 | 5,287 | D | | | | | | | | | | | | | | |
5/2/23 06:06 | 4/28/23 | GLSI | Health | Drug | Pharmaceutical Preparations | Thompson Jaye | TX | O | VP Clini | P | 3 | 11.22 | 0 | 0 | 0 | 259 | D | | | | | | | | | | | | | | |
4/21/23 06:05 | 4/19/23 | GLSI | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 78 | 11.10 | 0 | 7 | 0 | 5,286 | D | | | | | | | | | | | | | | |
4/20/23 06:05 | 4/18/23 | GLSI | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 22 | 11.12 | 0 | 2 | 0 | 5,279 | D | | | | | | | | | | | | | | |
4/12/23 06:05 | 4/11/23 | GLSI | Health | Drug | Pharmaceutical Preparations | Thompson Jaye | TX | O | VP Clini | P | 12 | 11.87 | 0 | 1 | 0 | 259 | D | | | | | | | | | | | | | | |
4/12/23 06:02 | 4/11/23 | GLSI | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 62 | 12.42 | 0 | 5 | 0 | 5,271 | D | | | | | | | | | | | | | | |
3/16/23 06:05 | 3/15/23 | GLSI | Health | Drug | Pharmaceutical Preparations | Thompson Jaye | TX | O | VP Clini | P | 3 | 12.71 | 0 | 0 | 0 | 258 | D | | | | | | | | | | | | | | |
3/13/23 07:15 | 3/10/23 | GLSI | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 12 | 12.12 | 0 | 1 | 0 | 2,737 | D | | | | | | | | | | | | | | |
2/28/23 06:03 | 2/24/23 | GLSI | Health | Drug | Pharmaceutical Preparations | Thompson Jaye | TX | O | VP Clini | P | 4 | 15.40 | 0 | 0 | 0 | 257 | D | | | | | | | | | | | | | | |
2/22/23 06:07 | 2/17/23 | GLSI | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 10 | 16.53 | 0 | 1 | 0 | 2,736 | D | | | | | | | | | | | | | | |
2/14/23 06:08 | 2/10/23 | GLSI | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 19 | 18.68 | 0 | 1 | 0 | 2,736 | D | | | | | | | | | | | | | | |
2/7/23 06:10 | 2/3/23 | GLSI | Health | Drug | Pharmaceutical Preparations | Thompson Jaye | TX | O | VP Clini | P | 5 | 20.84 | 0 | 0 | 0 | 257 | D | | | | | | | | | | | | | | |
1/31/23 06:15 | 1/27/23 | GLSI | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 39 | 19.35 | 0 | 2 | 0 | 2,735 | D | | | | | | | | | | | | | | |
1/30/23 06:15 | 1/27/23 | GLSI | Health | Drug | Pharmaceutical Preparations | Thompson Jaye | TX | O | VP Clini | P | 5 | 19.20 | 0 | 0 | 0 | 257 | D | | | | | | | | | | | | | | |
1/24/23 06:05 | 1/20/23 | GLSI | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 26 | 17.37 | 0 | 2 | 0 | 2,733 | D | | | | | | | | | | | | | | |
1/17/23 06:02 | 1/13/23 | GLSI | Health | Drug | Pharmaceutical Preparations | Thompson Jaye | TX | O | VP Clini | P | 4 | 16.50 | 0 | 0 | 0 | 257 | D | | | | | | | | | | | | | | |
1/10/23 06:05 | 1/6/23 | GLSI | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 23 | 15.18 | 0 | 2 | 0 | 2,731 | D | | | | | | | | | | | | | | |
1/3/23 06:05 | 12/29/22 | GLSI | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 61 | 15.19 | 0 | 4 | 0 | 2,730 | D | | | | | | | | | | | | | | |
12/20/22 06:05 | 12/16/22 | GLSI | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 13 | 13.01 | 0 | 1 | 0 | 2,726 | D | | | | | | | | | | | | | | |
12/20/22 06:05 | 12/16/22 | GLSI | Health | Drug | Pharmaceutical Preparations | Thompson Jaye | TX | O | VP Clini | P | 3 | 12.94 | 0 | 0 | 0 | 256 | D | | | | | | | | | | | | | | |
12/13/22 06:05 | 12/9/22 | GLSI | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 26 | 13.11 | 0 | 2 | 0 | 2,725 | D | | | | | | | | | | | | | | |
12/6/22 06:15 | 12/2/22 | GLSI | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 14 | 13.84 | 0 | 1 | 0 | 2,723 | D | | | | | | | | | | | | | | |
12/6/22 06:15 | 12/2/22 | GLSI | Health | Drug | Pharmaceutical Preparations | Thompson Jaye | TX | O | VP Clini | P | 3 | 13.98 | 0 | 0 | 0 | 256 | D | | | | | | | | | | | | | | |
11/4/22 06:15 | 11/2/22 | GLSI | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 18 | 8.79 | 0 | 2 | 0 | 2,722 | D | | | | | | | | | | | | | | |
10/17/22 07:00 | 10/14/22 | GLSI | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 29 | 9.75 | 0 | 3 | 0 | 2,720 | D | | | | | | | | | | | | | | |
10/11/22 06:05 | 10/7/22 | GLSI | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 19 | 9.72 | 0 | 2 | 0 | 2,717 | D | | | | | | | | | | | | | | |
10/4/22 06:05 | 9/30/22 | GLSI | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 9 | 9.46 | 0 | 1 | 0 | 2,715 | D | | | | | | | | | | | | | | |
10/3/22 06:15 | 9/29/22 | GLSI | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 9 | 9.23 | 0 | 1 | 0 | 2,714 | D | | | | | | | | | | | | | | |
6/27/22 06:05 | 6/24/22 | GLSI | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 265 | 9.13 | 0 | 29 | 1 | 5,419 | M | | | | | | | | | | | | | | |
6/17/22 06:05 | 6/16/22 | GLSI | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 57 | 7.13 | 0 | 8 | 0 | 2,684 | D | | | | | | | | | | | | | | |
6/15/22 06:05 | 6/14/22 | GLSI | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 95 | 7.91 | 0 | 12 | 0 | 2,676 | D | | | | | | | | | | | | | | |
6/13/22 06:04 | 6/10/22 | GLSI | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 100 | 8.33 | 0 | 12 | 0 | 2,664 | D | | | | | | | | | | | | | | |
6/10/22 06:05 | 6/9/22 | GLSI | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 49 | 10.90 | 0 | 5 | 0 | 1,243 | D | | | | | | | | | | | | | | |
6/8/22 06:07 | 6/7/22 | GLSI | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 51 | 8.55 | 0 | 6 | 0 | 1,239 | D | | | | | | | | | | | | | | |
6/6/22 06:05 | 6/3/22 | GLSI | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 77 | 8.35 | 0 | 9 | 1 | 1,233 | D | | | | | | | | | | | | | | |
6/3/22 06:05 | 6/2/22 | GLSI | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 50 | 7.38 | 0 | 7 | 1 | 1,224 | D | | | | | | | | | | | | | | |
4/26/22 06:05 | 4/25/22 | GLSI | Health | Drug | Pharmaceutical Preparations | Daugherty Frank Joseph | TX | DO | Chief Me | P | 16 | 16.25 | 0 | 1 | 1 | 90 | D | | | | | | | | | | | | | | |
4/22/22 06:04 | 4/21/22 | GLSI | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 97 | 16.09 | 0 | 6 | 0 | 1,217 | D | | | | | | | | | | | | | | |
4/21/22 06:03 | 4/19/22 | GLSI | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 100 | 16.74 | 0 | 6 | 0 | 1,211 | D | | | | | | | | | | | | | | |
4/20/22 06:02 | 4/19/22 | GLSI | Health | Drug | Pharmaceutical Preparations | Thompson Jaye | TX | O | VP Clini | P | 8 | 16.74 | 0 | 1 | 0 | 256 | D | | | | | | | | | | | | | | |
2/14/22 06:06 | 2/11/22 | GLSI | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 109 | 19.80 | 0 | 6 | 0 | 1,205 | D | | | | | | | | | | | | | | |
2/8/22 06:02 | 2/4/22 | GLSI | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 98 | 19.59 | 0 | 5 | 0 | 1,199 | D | | | | | | | | | | | | | | |
2/1/22 06:01 | 1/31/22 | GLSI | Health | Drug | Pharmaceutical Preparations | Thompson Jaye | TX | O | VP Clini | P | 9 | 18.47 | 0 | 1 | 0 | 255 | D | | | | | | | | | | | | | | |
1/24/22 06:08 | 1/21/22 | GLSI | Health | Drug | Pharmaceutical Preparations | Thompson Jaye | TX | O | VP Clini | P | 8 | 16.33 | 0 | 1 | 0 | 255 | D | | | | | | | | | | | | | | |
1/24/22 06:08 | 1/21/22 | GLSI | Health | Drug | Pharmaceutical Preparations | Hallock Kenneth | TX | D | | P | 5 | 16.32 | 0 | 0 | 0 | 397 | D | | | | | | | | | | | | | | |
1/19/22 06:09 | 1/18/22 | GLSI | Health | Drug | Pharmaceutical Preparations | Thompson Jaye | TX | O | VP Clini | P | 9 | 18.87 | 0 | 1 | 0 | 254 | D | | | | | | | | | | | | | | |
1/18/22 06:05 | 1/13/22 | GLSI | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 20 | 19.99 | 0 | 1 | 0 | 1,194 | D | | | | | | | | | | | | | | |
1/14/22 06:06 | 1/13/22 | GLSI | Health | Drug | Pharmaceutical Preparations | Thompson Jaye | TX | O | VP Clini | P | 20 | 19.99 | 0 | 1 | 0 | 254 | D | | | | | | | | | | | | | | |
1/14/22 06:05 | 1/13/22 | GLSI | Health | Drug | Pharmaceutical Preparations | Daugherty Frank Joseph | TX | DO | Chief Me | P | 20 | 19.99 | 0 | 1 | 1 | 89 | D | | | | | | | | | | | | | | |
1/4/22 06:05 | 1/3/22 | GLSI | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 49 | 23.82 | 0 | 2 | 0 | 1,193 | D | | | | | | | | | | | | | | |
12/16/21 06:08 | 12/14/21 | GLSI | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 50 | 27.17 | 0 | 2 | 0 | 1,191 | D | | | | | | | | | | | | | | |
12/16/21 06:05 | 12/14/21 | GLSI | Health | Drug | Pharmaceutical Preparations | Daugherty Frank Joseph | TX | DO | Chief Me | P | 30 | 26.99 | 0 | 1 | 1 | 88 | D | | | | | | | | | | | | | | |
12/16/21 06:02 | 12/14/21 | GLSI | Health | Drug | Pharmaceutical Preparations | McWilliams David | TX | D | | P | 6 | 27.56 | 0 | 0 | 0 | 620 | D | | | | | | | | | | | | | | |
4/14/21 07:30 | 4/13/21 | GLSI | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DO | CEO,CFO | P | 100 | 36.98 | 0 | 3 | 0 | 7,782 | D | | | | | | | | | | | | | | |
11/27/20 07:00 | 11/24/20 | GLSI | Health | Drug | Pharmaceutical Preparations | Hallock Kenneth | TX | D | | P | 5 | 5.39 | 0 | 1 | 0 | 397 | I | | | | | | | | | | | | | | |
11/25/20 07:00 | 11/23/20 | GLSI | Health | Drug | Pharmaceutical Preparations | Daugherty Frank Joseph | TX | DO | Chief Me | P | 5 | 5.10 | 0 | 1 | 1 | 87 | D | | | | | | | | | | | | | | |
11/24/20 08:00 | 11/20/20 | GLSI | Health | Drug | Pharmaceutical Preparations | McWilliams David | TX | D | | P | 8 | 5.40 | 0 | 2 | 0 | 620 | D | | | | | | | | | | | | | | |
11/24/20 08:00 | 11/20/20 | GLSI | Health | Drug | Pharmaceutical Preparations | Hallock Kenneth | TX | D | | P | 5 | 5.37 | 0 | 1 | 0 | 396 | I | | | | | | | | | | | | | | |
11/24/20 08:00 | 11/20/20 | GLSI | Health | Drug | Pharmaceutical Preparations | Rothe Eric | TX | D | | P | 11 | 5.40 | 0 | 2 | 1 | 313 | D | | | | | | | | | | | | | | |
11/20/20 07:00 | 11/19/20 | GLSI | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DO | CEO,CFO | P | 11 | 5.40 | 0 | 2 | 0 | 7,780 | D | | | | | | | | | | | | | | |
10/9/20 18:02 | 9/29/20 | GLSI | Health | Drug | Pharmaceutical Preparations | Patel Kinnary | TX | T | | M.d | 0 | 0.00 | 0 | 129 | 3 | 5,185 | I | | | | | | | | | | | | | | |
10/1/20 08:00 | 9/29/20 | GLSI | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DO | CEO,CFO | P | 77 | 4.60 | 0 | 17 | 0 | 7,778 | D | | | | | | | | | | | | | | |
10/1/20 08:00 | 9/29/20 | GLSI | Health | Drug | Pharmaceutical Preparations | Hallock Kenneth | TX | D | | P | 38 | 4.60 | 0 | 8 | 2 | 395 | I | | | | | | | | | | | | | | |
9/30/20 21:01 | 9/29/20 | GLSI | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DO | CEO,CFO | M.d | 0 | 0.00 | 0 | 1,665 | 36 | 6,353 | M | | | | | | | | | | | | | | |
9/30/20 21:00 | 9/29/20 | GLSI | Health | Drug | Pharmaceutical Preparations | Hallock Kenneth | TX | D | | M.d | 0 | 0.00 | 0 | 117 | 43 | 387 | I | | | | | | | | | | | | | | |
9/30/20 21:00 | 9/29/20 | GLSI | Health | Drug | Pharmaceutical Preparations | McWilliams David | TX | D | | M.d | 0 | 0.00 | 0 | 172 | 38 | 619 | D | | | | | | | | | | | | | | |
9/29/20 21:42 | 9/29/20 | GLSI | Health | Drug | Pharmaceutical Preparations | Hallock Kenneth | TX | D | | P | 430 | 5.75 | 0 | 75 | 41 | 257 | I | | | | | | | | | | | | | | |
9/29/20 21:42 | 9/29/20 | GLSI | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DO | CEO,CFO | P | 657 | 5.75 | 0 | 114 | 15 | 864 | D | | | | | | | | | | | | | | |
9/29/20 21:42 | 9/29/20 | GLSI | Health | Drug | Pharmaceutical Preparations | Daugherty Frank Joseph | TX | DO | Chief Me | P | 10 | 5.75 | 0 | 2 | 2 | 86 | D | | | | | | | | | | | | | | |
9/29/20 21:41 | 9/29/20 | GLSI | Health | Drug | Pharmaceutical Preparations | McWilliams David | TX | D | | P | 15 | 5.75 | 0 | 3 | 1 | 447 | D | | | | | | | | | | | | | | |